SCHEMBL12377867

SCHEMBL12377867

Cc1cccc(-c2nc(C(=O)NCC#N)co2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 8/20 0.51
HDAC8 Q9BY41 8/20 0.51
HDAC6 Q9UBN7 8/20 0.51
CTSL P07711 2/20 0.42
PDE4B Q07343 3/20 0.42
CTSB P07858 1/20 0.42
DGAT2 Q96PD7 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
MAPK1 P28482 1/20 0.40
OPRK1 P41145 1/20 0.40
HTT P42858 1/20 0.40
CCR6 P51684 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TLR9 Q9NR96 1/20 0.40
TLR8 Q9NR97 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12377853 0.86 HDAC1 (0.54) HDAC1HDAC8HDAC6PDE4BDGAT2
SCHEMBL12377866 0.83 HDAC1 (0.51) HDAC1HDAC8HDAC6PDE4BMEN1
SCHEMBL12377859 0.82 HDAC1 (0.58) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL12377868 0.79 SLC9A1 (0.54) CTSLCTSBALDH1A1MEN1LMNA
SCHEMBL10029551 0.78 HDAC1 (0.51) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL12377852 0.77 HDAC1 (0.51) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL9900075 0.77 ALDH1A1 (0.68) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL12377858 0.75 HSD17B1 (0.48) HDAC1HDAC8HDAC6PDE4BALDH1A1
SCHEMBL12339938 0.74 HDAC1 (0.63) HDAC1HDAC8HDAC6PDE4BDGAT2
SCHEMBL6976762 0.73 NPC1 (0.45) ALDH1A1MEN1LMNATP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998954-B2 Pyrimidodiazepinone derivative KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-08-16 US disclosed
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KYOWA HAKKO KIRIN CO., LTD (JP) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190775-A1 PYRIMIDODIAZEPINONE DERIVATIVE KCNJ1, KCNJ11, ADRA1D HDAC1 120/4885HDAC8 462/4885HDAC6 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.